Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 534 of the 534 references it cites were found in a registry or an index.

Dipeptidyl-Peptidase IV from Bench to Bedside: An Update on Structural Properties, Functions, and Clinical Aspects of the Enzyme DPP IV

Lambeir, Anne-Marie, Durinx, Christine, Scharpé, Simon, De Meester, Ingrid · 2003 · Critical Reviews in Clinical Laboratory Sciences

Abstract

Dipeptidyl-peptidase IV/CD26 (DPP IV) is a cell-surface protease belonging to the prolyloligopeptidase family. It selectively removes the N-terminal dipeptide from peptides with proline or alanine in the second position. Apart from its catalytic activity, it interacts with several proteins, for instance, adenosine deaminase, the HIV gp120 protein, fibronectin, collagen, the chemokine receptor CXCR4, and the tyrosine phosphatase CD45. DPP IV is expressed on a specific set of T lymphocytes, where it is up-regulated after activation. It is also expressed in a variety of tissues, primarily on endothelial and epithelial cells. A soluble form is present in plasma and other body fluids. DPP IV has been proposed as a diagnostic or prognostic marker for various tumors, hematological malignancies, immunological, inflammatory, psychoneuroendocrine disorders, and viral infections. DPP IV truncates many bioactive peptides of medical importance. It plays a role in glucose homeostasis through proteolytic inactivation of the incretins. DPP IV inhibitors improve glucose tolerance and pancreatic islet cell function in animal models of type 2 diabetes and in diabetic patients. The role of DPP IV/ CD26 within the immune system is a combination of its exopeptidase activity and its interactions with different molecules. This enables DPP IV/CD26 to serve as a co-stimulatory molecule to influence T cell activity and to modulate chemotaxis. DPP IV is also implicated in HIV-1 entry, malignant transformation, and tumor invasion.

Overview

Integrity signals

Registry

Crossref · 10.1080/713609354

Cites

534 of 534 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 529 references

Research works printed but not linked: 51

  1. Martin RA, 1993, Extended DPP-IV substrate specificity? Biochim Biophys Acta, 1164, 252
  2. Heymann E, 1986, Biomed Biochim Acta, 45, 575
  3. Heiduschka P, 1989, Pharmazie, 44, 778
  4. Barth A, 1974, Acta Biol Med Ger, 32, 157
  5. Gonzalez-Gronow M, 2001, Biochem J, 355, 397, 10.1042/bj3550397 · doi:10.1042/bj3550397
  6. Kenny AJ, 1977, Acta Biol Med Ger, 36, 1575
  7. Sterchi E., 1981, Pediatr Res, 15, 884
  8. Büchsel R, 1986, Eur J Cell Biol, 40, 53
  9. Riemann D, 2001, Biochem J, 354, 47, 10.1042/bj3540047 · doi:10.1042/bj3540047
  10. Küllertz G, 1989, Z Med Lab Diagn, 30, 273
  11. Vanhoof G, 1992, Eur J Clin Chem Clin Biochem, 30, 333
  12. Buhling F, 1994, Nat Immun, 13, 270
  13. Munoz E, 1992, Immunology, 77, 43
  14. Vanham G, 1993, J Acquir Immune Defic Syndr, 6, 749
  15. Annunziato F, 1998, Eur Cytokine Netw, 9, 12
  16. Stefanovic V, 1993, Immunology, 80, 465
  17. Cuchacovich M, 2001, Clin Exp Rheumatol, 19, 673
  18. Kasahara Y, 1983, Jpn J Clin Chem, 12, 89
  19. Antczak C, 2001, J Biol Regul Homeost Agents, 15, 130
  20. Stange T, 2000, Eur J Histochem, 44, 157
  21. Ten Kate J, 1986, Anticancer Res, 6, 983
  22. Kajiyama H, 2002, Cancer Res, 62, 2753
  23. Verstovsek S, 2000, Oncology (Huntingt), 14, 17
  24. Schonermarck U, 2000, Clin Exp Rheumatol, 18, 457
  25. Muller A, 2000, J Pathol, 192, 113, 10.1002/1096-9896(2000)9999:9999<::aid-path656>3.0.co;2-m · doi:10.1002/1096-9896(2000)9999:9999<::aid-path656>3.0.co;2-m
  26. Strunk T, 2000, Ann Neurol, 47, 269, 10.1002/1531-8249(200002)47:2<269::aid-ana23>3.0.co;2-g · doi:10.1002/1531-8249(200002)47:2<269::aid-ana23>3.0.co;2-g
  27. Kähne T, 1999, Int J Mol Med, 4, 3
  28. Zukowska-Grojec Z, 1996, Am J Physiol, 270, H796
  29. Neuropeptide Zukowska-Grojec Z., 1997, Drug News Perspectives, 10, 587
  30. Pappas TN, 1985, Am J Physiol, 248, G118
  31. Zubrzycka M, 2000, Endocr Regul, 34, 195
  32. Ahmad S, 1992, J Pharmacol Exp Ther, 260, 1257
  33. Hartrodt B, 1982, Pharmazie, 37, 72
  34. Sherwood NM, 2000, Endocr Rev, 21, 619
  35. Dhanvantari S, 1996, Mol Endocrinol, 10, 342
  36. Cheeseman CI, 1996, Am J Physiol, 271, G477
  37. Krarup T, 1985, Am J Physiol, 249, E195
  38. Deacon CF, 2000, J Clin Endocrinol Metab, 85, 3575
  39. Kato I, 1994, Evidence for improved glucose tolerance and enhanced insulin secretion by VIP and PHM-27 in vivo. J Biol Chem, 269, 21223
  40. Karlsson S, 1998, Am J Physiol, 274, E124
  41. Rocca AS, 1999, Endocrinology, 140, 1687, 10.1210/endo.140.4.6643 · doi:10.1210/endo.140.4.6643 · Paper page
  42. Deacon CF, 1995, J Clin Endocrinol Metab, 80, 952
  43. Gutzwiller JP, 1999, Am J Physiol, 276, R1541
  44. Schön E, 1985, Biomed Biochim Acta, 44, K9
  45. Gines S, 2002, Biochem J, 361, 203, 10.1042/bj3610203 · doi:10.1042/bj3610203
  46. Luster AD, 1998, Proc Assoc Am Physicians, 110, 183
  47. Ho L, 2001, Clin Cancer Res, 7, 2031
  48. Albino AP, 1992, Oncogene, 7, 2315
  49. Fountain JW, 1990, Cancer Surv, 9, 645
  50. Fischer G, 1983, Pharmazie, 38, 249
  51. Tiruppathi C, 1993, Am J Physiol, 265, G81

Cited by

See all 1,000

Metadata

Authors
Lambeir, A.-M., Durinx, C., Scharpé, S., & De Meester, I.
Affiliations
University of Antwerp (BE)
Corresponding author
Lambeir, Anne-Marie
Venue
Critical Reviews in Clinical Laboratory Sciences
Published
2003-01
Volume
40
Issue
3
Pages
209-294
ISSN
  • 1040-8363 (ISSN-L)
  • 1549-781X
OpenAlex
W2028849170
Cited by
955
References
529
Citations by year
2026: 15 · 2025: 32 · 2024: 49 · 2023: 35 · 2022: 53 · 2021: 62 · 2020: 80 · 2019: 50 · 2018: 43 · 2017: 44 · 2016: 57 · 2015: 49 · 2014: 43 · 2013: 50 · 2012: 40
FWCI
2.44
Type
journal article
Language
en
Open access
closed
Locations
  • Critical Reviews in Clinical Laboratory Sciences (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Peptidase Inhibition and Analysis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
Keywords
dipeptidyl peptidase IV, CD26, T cells, DPP-4 inhibitors, type 2 diabetes, tumor markers, HIV-1 entry, CXCR4, CD45, T cell costimulation, chemotaxis, tumor invasion, glucose homeostasis
MeSH terms
Amino Acid Sequence, Animals, Base Sequence, Disease Models, Animal, Humans, Molecular Sequence Data, T-Lymphocytes, Biomarkers, Dipeptidyl Peptidase 4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dipeptidyl-Peptidase IV from Bench to Bedside: An Update on Structural Properties, Functions, and Clinical Aspects of the Enzyme DPP IV. https://app.cochat.ai/papers/10.1080/713609354
The paper
Lambeir, A.-M., Durinx, C., Scharpé, S., & De Meester, I. (2003). Dipeptidyl-Peptidase IV from Bench to Bedside: An Update on Structural Properties, Functions, and Clinical Aspects of the Enzyme DPP IV. Critical Reviews in Clinical Laboratory Sciences. https://doi.org/10.1080/713609354

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.